Hepatitis E vaccine

被引:31
作者
Aggarwal, Rakesh [2 ]
Jameel, Shahid [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India
关键词
hepatitis; hepatitis E; HEV; vaccine;
D O I
10.1007/s12072-008-9071-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis E is an emerging disease in resource-poor regions of the world. It is estimated that about 2 billion people live in areas endemic for this disease. The inability to reproducibly culture hepatitis E virus makes it impossible to develop traditional live or inactivated vaccines. However, significant progress has been made in developing and testing recombinant subunit vaccines based on the viral capsid protein. This review summarizes these efforts.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 65 条
[51]   Safety and efficacy of a recombinant hepatitis E vaccine [J].
Shrestha, Mrigendra Prasad ;
Scott, Robert McNair ;
Joshi, Durga Man ;
Mammen, Mammen P., Jr. ;
Thapa, Gyan Bahadur ;
Thapa, Narbada ;
Myint, Khin Saw Aye ;
Fourneau, Marc ;
Kuschner, Robert A. ;
Shrestha, Sanjaya Kumar ;
David, Marie Pierre ;
Seriwatana, Jitvimol ;
Vaughn, David W. ;
Safary, Assad ;
Endy, Timothy P. ;
Innis, Bruce L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (09) :895-903
[52]   DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration [J].
Takamura, S ;
Niikura, M ;
Li, TC ;
Takeda, N ;
Kusagawa, S ;
Takebe, Y ;
Miyamura, T ;
Yasutomi, Y .
GENE THERAPY, 2004, 11 (07) :628-635
[53]   In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes [J].
Tam, AW ;
White, R ;
Yarbough, PO ;
Murphy, BJ ;
McAtee, CP ;
Lanford, RE ;
Fuerst, TR .
VIROLOGY, 1997, 238 (01) :94-102
[54]   HEPATITIS-E VIRUS (HEV) - MOLECULAR-CLONING AND SEQUENCING OF THE FULL-LENGTH VIRAL GENOME [J].
TAM, AW ;
SMITH, MM ;
GUERRA, ME ;
HUANG, CC ;
BRADLEY, DW ;
FRY, KE ;
REYES, GR .
VIROLOGY, 1991, 185 (01) :120-131
[55]   Seroreactivity to hepatitis E virus in areas where the disease is not endemic [J].
Thomas, DL ;
Yarbough, PO ;
Vlahov, D ;
Tsarev, SA ;
Nelson, KE ;
Saah, AJ ;
Purcell, RH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) :1244-1247
[56]   CHARACTERIZATION OF A PROTOTYPE STRAIN OF HEPATITIS-E VIRUS [J].
TSAREV, SA ;
EMERSON, SU ;
REYES, GR ;
TSAREVA, TS ;
LEGTERS, LJ ;
MALIK, IA ;
IQBAL, M ;
PURCELL, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :559-563
[57]   SUCCESSFUL PASSIVE AND ACTIVE IMMUNIZATION OF CYNOMOLGUS MONKEYS AGAINST HEPATITIS-E [J].
TSAREV, SA ;
TSAREVA, TS ;
EMERSON, SU ;
GOVINDARAJAN, S ;
SHAPIRO, M ;
GERIN, JL ;
PURCELL, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10198-10202
[58]   Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge [J].
Tsarev, SA ;
Tsareva, TS ;
Emerson, SU ;
Govindarajan, S ;
Shapiro, M ;
Gerin, JL ;
Purcell, RH .
VACCINE, 1997, 15 (17-18) :1834-1838
[59]   Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery cytokine genes [J].
Tuteja, R ;
Li, TC ;
Takeda, N ;
Jameel, S .
VIRAL IMMUNOLOGY, 2000, 13 (02) :169-178
[60]  
Wang L, 2004, WORLD J GASTROENTERO, V10, P2157